Condition: Gastrointestinal Cancer · Urologic Cancer · Gynecologic Cancer · Sponsor: Sykehuset Telemark
PALLSOFT is a randomized, open-label, non-inferiority phase III, multicenter, national trial that will investigate whether the patient-reported symptomatic effect of palliative radiotherapy delivered in 1-2 fractions is non-inferior to palliative radiotherapy delivered in five fractions in patients with pelvic soft tissue tumors from either gastrointestinal, urological or gynecological cancer. Health-related quality of life, toxicities, survival and prognostic and predictive biomarkers will be assessed as secondary and explorative endpoints.
This description comes directly from the study's public registry record.
Kjersti Skipar, MD · +47 98444114 · kjeski@sthf.no
Harald Ragnum, MD, PhD · +47 90792571 · harrag@sthf.no
Always discuss trial participation with your own doctor first.
| Helse Møre og Romsdal | Ålesund, Norway | Recruiting |
| Haukeland universitetssykehus | Bergen, Norway | Recruiting |
| Nordlandssykehuset Bodø | Bodø, Norway | Recruiting |
| Vestre Viken HF | Drammen, Norway | Recruiting |
| Sykehuset Innlandet HF | Gjøvik, Norway | Recruiting |
| Sørlandet sykehus HF | Kristiansand, Norway | Recruiting |
| Oslo Universitetssykehus | Oslo, Norway | Recruiting |
| Sykehuset Telemark HF | Skien, Norway | Recruiting |
| Stavanger Universitetssykehus | Stavanger, Norway | Recruiting |
| Universitetssykehuset i Nord-Norge | Tromsø, Norway | Recruiting |
| St. Olavs Hospital HF | Trondheim, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06398314